JP2006524672A - ウイルス感染の治療において使用するための複素環式化合物 - Google Patents

ウイルス感染の治療において使用するための複素環式化合物 Download PDF

Info

Publication number
JP2006524672A
JP2006524672A JP2006506149A JP2006506149A JP2006524672A JP 2006524672 A JP2006524672 A JP 2006524672A JP 2006506149 A JP2006506149 A JP 2006506149A JP 2006506149 A JP2006506149 A JP 2006506149A JP 2006524672 A JP2006524672 A JP 2006524672A
Authority
JP
Japan
Prior art keywords
alkyl
furo
decyl
pyrimidin
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006506149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006524672A5 (https=
Inventor
クリストファー マクギガン，
ヤン バルザリーニ，
エリック デ・クレルク，
Original Assignee
ユニバーシティー・カッレッジ・カーディフ・コンサルタンツ・リミテッド
レガ・ファンデーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティー・カッレッジ・カーディフ・コンサルタンツ・リミテッド, レガ・ファンデーション filed Critical ユニバーシティー・カッレッジ・カーディフ・コンサルタンツ・リミテッド
Publication of JP2006524672A publication Critical patent/JP2006524672A/ja
Publication of JP2006524672A5 publication Critical patent/JP2006524672A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2006506149A 2003-04-25 2004-04-21 ウイルス感染の治療において使用するための複素環式化合物 Withdrawn JP2006524672A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0309506 2003-04-25
PCT/GB2004/001687 WO2004096813A1 (en) 2003-04-25 2004-04-21 Heterocyclic compounds for use in the treatment of viral infections

Publications (2)

Publication Number Publication Date
JP2006524672A true JP2006524672A (ja) 2006-11-02
JP2006524672A5 JP2006524672A5 (https=) 2009-04-16

Family

ID=33397005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506149A Withdrawn JP2006524672A (ja) 2003-04-25 2004-04-21 ウイルス感染の治療において使用するための複素環式化合物

Country Status (7)

Country Link
US (1) US20070191373A1 (https=)
EP (1) EP1622913A1 (https=)
JP (1) JP2006524672A (https=)
AU (1) AU2004234110A1 (https=)
CA (1) CA2523739A1 (https=)
MX (1) MXPA05010802A (https=)
WO (1) WO2004096813A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013517243A (ja) * 2010-01-14 2013-05-16 サノフイ ２，５−置換されたオキサゾロピリミジン誘導体

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083923A (en) * 1997-10-31 2000-07-04 Isis Pharmaceuticals Inc. Liposomal oligonucleotide compositions for modulating RAS gene expression
EP2318415B1 (en) 2008-07-15 2013-02-20 Sanofi Oxazolopyrimidines as edg-1 receptor agonists
AR079980A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
AR079981A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de acido carboxilico que comprenden un anillo de oxoazolopirimidina 2,5,7- sustituido
CN102791717B (zh) * 2010-01-14 2016-03-30 赛诺菲 具有2,5-取代的噁唑并嘧啶环的羧酸衍生物
AR082453A1 (es) 2010-04-21 2012-12-12 Novartis Ag Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
GB201111779D0 (en) 2011-07-08 2011-08-24 Univ Cardiff Chemical compounds
WO2014140077A1 (en) 2013-03-14 2014-09-18 Glaxosmithkline Intellectual Property (No.2) Limited Furopyridines as bromodomain inhibitors
BR112022025710A2 (pt) 2020-06-19 2023-03-07 Bayer Ag 1,3,4-oxadiazol pirimidinas e 1,3,4-oxadiazol piridinas como fungicidas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444148A1 (en) * 2001-04-11 2002-10-24 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013517243A (ja) * 2010-01-14 2013-05-16 サノフイ ２，５−置換されたオキサゾロピリミジン誘導体

Also Published As

Publication number Publication date
EP1622913A1 (en) 2006-02-08
WO2004096813A1 (en) 2004-11-11
MXPA05010802A (es) 2005-12-14
AU2004234110A1 (en) 2004-11-11
CA2523739A1 (en) 2004-11-11
US20070191373A1 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
JP2743099B2 (ja) 炭素環状ヌクレオシドおよびヌクレオチド
KR100441638B1 (ko) 새로운 에이사이클릭 뉴클레오사이드 포스포네이트유도체, 그의 염 및 합성 방법
JP4514242B2 (ja) 抗ウイルスピリミジンヌクレオシド類似体
JP3421335B2 (ja) 鏡像異性的に純粋なβ−Ｄ−（−）−ジオキソラン−ヌクレオシド
SU1535377A3 (ru) Способ получени производных ароматических аминоспиртов или их фармакологически приемлемых солей
AU2006226182B2 (en) Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
JP2025527298A (ja) 三環式化合物及びその医薬用途
DE69330274T2 (de) Enantiomerisch reine beta-d-dioxolan-nukleoside
EP0343133B1 (en) Derivatives of purine, process for their preparation and a pharmaceutical preparation
MXPA97002488A (en) Compounds of purine and guanine as inhibitors of
EP0502690B1 (en) Cyclopropane derivative
JP2006524672A (ja) ウイルス感染の治療において使用するための複素環式化合物
HU202550B (en) Process for producing 2-substituted adenosyl derivatives and pharmaceutical compositions comprising such compounds
KR20180134374A (ko) 2'-플루오로-6'-메틸렌-탄소환식 아데노신(fmca) 및 2'-플루오로-6'-메틸렌-탄소환식 구아노신(fmcg)의 합성
PL150841B1 (en) Purine compounds.
EP0173624A2 (en) 4-(guanin-9-yl) butanals and antiviral compositions containing them
CN1921867B (zh) 用于治疗hiv感染的膦酸核苷衍生物
AU3760793A (en) Antiviral phosphonic acid derivatives of purine analogues
US5565461A (en) Derivatives of purine, process for their preparation and a pharmaceutical preparation
CN113164506A (zh) 二核苷酸化合物及其前体药物
AU701659B2 (en) Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides
SK278012B6 (en) Thienopyrane derivatives, method of their production and their use
FR2571374A1 (fr) Nouveaux derives de 5-fluoro-2'-desoxyuridine et leurs sels, leur procede de preparation, et agents antitumoraux les contenant
CN111918870A (zh) 氘代的低聚核苷酸及前体药物
EP0366171B1 (en) Nucleoside derivatives

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070314

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20071228

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090406

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090508